Synaptic protein CSF levels relate to memory scores in individuals without dementia

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Background: We investigated how cerebrospinal fluid levels of synaptic proteins associate with memory function in normal cognition (CN) and mild cognitive impairment (MCI), and investigated the effect of amyloid positivity on these associations. Methods: We included 242 CN (105(43%) abnormal amyloid...

Podrobná bibliografie
Hlavní autoři:	Wesenhagen, KEJ, de Leeuw, DM, Tomassen, J, Gobom, J, Bos, I, Vos, SJB, Martinez-Lage, P, Tainta, M, Popp, J, Peyratout, G, Tsolaki, M, Vandenberghe, R, Freund-Levi, Y, Verhey, F, Lovestone, S, Streffer, J, Dobricic, V, Blennow, K, Scheltens, P, Smit, AB, Bertram, L, Teunissen, CE, Zetterberg, H, Tijms, BM
Médium:	Journal article
Jazyk:	English
Vydáno:	BioMed Central 2025

Podobné jednotky

Synaptic protein CSF levels relate to memory scores in individuals without dementia
Autor: Kirsten E. J. Wesenhagen, a další
Vydáno: (2025-03-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Autor: Betty Marije Tijms, a další
Vydáno: (2021-08-01)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
Autor: Elles Konijnenberg, a další
Vydáno: (2020-05-01)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Autor: Delvenne, A, a další
Vydáno: (2024)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
Autor: Delvenne, A, a další
Vydáno: (2024)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Autor: Aurore Delvenne, a další
Vydáno: (2024-07-01)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Autor: Pieter Jelle Visser, a další
Vydáno: (2022-05-01)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Autor: Pieter Jelle Visser, a další
Vydáno: (2022-03-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Autor: Westwood, S, a další
Vydáno: (2020)

Inflammatory biomarkers in Alzheimer's disease plasma
Autor: Morgan, A, a další
Vydáno: (2019)

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
Autor: ten Kate, M, a další
Vydáno: (2018)

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Autor: Shi, L, a další
Vydáno: (2019)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
Autor: Jan Homann, a další
Vydáno: (2022-03-01)

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Autor: Alexander Neumann, a další
Vydáno: (2023-10-01)

Sex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Autor: Jin Xu, a další
Vydáno: (2021-11-01)

P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
Autor: Kirsten E. J. Wesenhagen, a další
Vydáno: (2022-07-01)

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Autor: Claudia Cicognola, a další
Vydáno: (2021-02-01)

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
Autor: Isabelle Bos, a další
Vydáno: (2018-07-01)

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Autor: Bos, I, a další
Vydáno: (2019)

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
Autor: Flora H. Duits, a další
Vydáno: (2021-01-01)

Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies
Autor: Liu Shi, a další
Vydáno: (2021-07-01)

Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
Autor: Chiara Giangrande, a další
Vydáno: (2023-07-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
Autor: Mikko Hölttä, a další
Vydáno: (2012-01-01)

Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
Autor: Jori Tomassen, a další
Vydáno: (2022-01-01)

Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks
Autor: Yuting Zhang, a další
Vydáno: (2022-11-01)

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis
Autor: Bridel, C, a další
Vydáno: (2019)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Autor: Elena Camporesi, a další
Vydáno: (2021-02-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
Autor: Eleonora M. Vromen, a další
Vydáno: (2022-01-01)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Autor: Aitana Sogorb-Esteve, a další
Vydáno: (2018-07-01)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Autor: Johanna Nilsson, a další
Vydáno: (2021-01-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
Autor: Nicholas J. Ashton, a další
Vydáno: (2021-06-01)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
Autor: Thomas K. Karikari, a další
Vydáno: (2022-06-01)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
Autor: Mara ten Kate, a další
Vydáno: (2017-09-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
Autor: Eline A. J. Willemse, a další
Vydáno: (2021-01-01)

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
Autor: Karl Hansson, a další
Vydáno: (2022-11-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Autor: Henrik Zetterberg, a další
Vydáno: (2021-02-01)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
Autor: Tina E. Brinkley, a další
Vydáno: (2022-06-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
Autor: Rosha Babapour Mofrad, a další
Vydáno: (2019-12-01)

Early diagnosis of silent coronary artery disease in diabetic subjects - are intense efforts worth while?
Autor: KEJ Airaksinen
Vydáno: (2001-07-01)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Autor: Nicholas J. Ashton, a další
Vydáno: (2019-12-01)